Dr. Hicham Skali is a staff cardiologist, a member of the Non-invasive Cardiovascular Imaging Program at Brigham and Women’s Hospital (BWH), and at Brigham and Women’s/ Massachusetts General Health Care Center at Foxborough. He is also the associate director of the BWH Cardiac Rehabilitation program. Dr. Skali is an instructor in medicine at Harvard Medical School.Dr. Skali received his medical degree from University Hassan II/Faculté de Medicine de Casablanca in Morocco. He completed an internal medicine residency and a cardiovascular medicine fellowship at St. Elizabeth’s Medical Center in Boston, followed by a cardiac imaging fellowship at BWH. Dr. Skali is certified as a diplomat in Internal Medicine and Cardiovascular Diseases, as well as board certified in nuclear cardiology and echocardiography.Dr. Skali is also director of the Cardiac Imaging Core Laboratory, and a senior member of the Clinical Endpoints Center at BWH. His research focuses on understanding the complex interactions between clinical and imaging biomarkers, as well as cardiovascular mortality and morbidity in high-risk populations with diabetes or kidney diseases. He has authored over 60 peer-reviewed publications. Dr. Lami is rated as an Advanced provider by MediFind in the treatment of Metabolic Syndrome. His top areas of expertise are Arrhythmias, Angina, Atherosclerosis, Pacemaker Implantation, and Cardiac Ablation.

Junyang Lou is a Cardiologist in Boston, Massachusetts. Dr. Lou is rated as an Advanced provider by MediFind in the treatment of Metabolic Syndrome. His top areas of expertise are Heart Attack, Apoplexy, Arterial Embolism, Angioplasty, and Aortic Valve Replacement.

Robert Giugliano is a Cardiologist in Boston,, Massachusetts. Dr. Giugliano is rated as an Advanced provider by MediFind in the treatment of Metabolic Syndrome. His top areas of expertise are Atrial Fibrillation, Acute Coronary Syndrome, Heart Attack, Percutaneous Coronary Intervention (PCI), and Coronary Artery Bypass Graft (CABG).

Michael Gavin is an Internal Medicine provider in Boston, Massachusetts. Dr. Gavin is rated as an Advanced provider by MediFind in the treatment of Metabolic Syndrome. His top areas of expertise are Mitral Valve Regurgitation, Heart Attack, Heart Failure, Angioplasty, and Pacemaker Implantation.

Joann Manson is a primary care provider, practicing in Endocrinologist in Boston, Massachusetts. Dr. Manson is rated as an Advanced provider by MediFind in the treatment of Metabolic Syndrome. Her top areas of expertise are Menopause, Type 2 Diabetes (T2D), Coronary Heart Disease, Hormone Replacement Therapy (HRT), and Tubal Ligation.

Wilson Colucci is a Cardiologist in Boston,, Massachusetts. Dr. Colucci is rated as an Advanced provider by MediFind in the treatment of Metabolic Syndrome. His top areas of expertise are Metabolic Syndrome, High Cholesterol, Cardiomyopathy, and Heart Failure.

Clyde Smith is a primary care provider, practicing in Internal Medicine in Jamaica Plain, Massachusetts. Dr. Smith is rated as an Experienced provider by MediFind in the treatment of Metabolic Syndrome. His top areas of expertise are Type 2 Diabetes (T2D), Gastrointestinal Fistula, Maturity Onset Diabetes of the Young, and Familial Hypertension.

Jorge Alvarez is a Cardiologist in Boston, Massachusetts. Dr. Alvarez is rated as an Advanced provider by MediFind in the treatment of Metabolic Syndrome. His top areas of expertise are Pulmonary Hypertension, Pulmonary Veno-Occlusive Disease, Stable Angina, Pacemaker Implantation, and Gastrostomy.

William Boden is a Cardiologist in Boston,, Massachusetts. Dr. Boden is rated as an Advanced provider by MediFind in the treatment of Metabolic Syndrome. His top areas of expertise are Angina, Coronary Heart Disease, Stable Angina, Percutaneous Coronary Intervention (PCI), and Heart Bypass Surgery.

Alberto Ramirez is a Cardiologist in Jamaica Plain, Massachusetts. Dr. Ramirez is rated as an Advanced provider by MediFind in the treatment of Metabolic Syndrome. His top areas of expertise are Stable Angina, Metabolic Syndrome, Heart Attack, and Fainting.

Christian T. Ruff, MD, MPH is the Director of General Cardiology in the Cardiovascular Division at Brigham and Women’s Hospital in Boston, MA and an Associate Professor of Medicine at Harvard Medical School. Dr. Ruff graduated from Harvard University, earned his medical degree at Johns Hopkins University School of Medicine, and his masters of public health from the Harvard School of Public Health. Dr. Ruff completed his internal medicine residency and cardiovascular medicine fellowship at the Brigham and Women’s Hospital.Dr. Ruff is a Senior Investigator in the Thrombolysis in Myocardial Infarction (TIMI) Study Group and serves the Director of the Genetics Core Laboratory and the Co-Chairman of the Clinical Events Committee. He has led a broad array of projects, ranging from investigator initiated studies of biomarkers and genetic variants to large clinical trials. Dr. Ruff has served on international clinical guideline committees and has been invited to give hundreds of lectures nationally and internationally. He has authored many scholarly articles, editorials, reviews, and book chapters that include the New England Journal of Medicine, Lancet, Journal of the American Medical Association, American Journal of Medicine, Circulation, Journal of the American College of Cardiology, and Nature Reviews Cardiology. Dr. Ruff is rated as an Experienced provider by MediFind in the treatment of Metabolic Syndrome. His top areas of expertise are Atrial Fibrillation, Heart Attack, Heart Failure, Cardiac Ablation, and Angioplasty.

Stephen D. Wiviott, MD, FACC is a graduate of University of Pennsylvania and Harvard Medical School (HMS, Honors). He served as a Medicine resident and Chief Medical Resident at Brigham and Women’s Hospital (BWH). Following his medical residency training, he served as a Cardiology fellow at Johns Hopkins Hospital. He is Associate Professor of Medicine at Harvard Medical School, and a Senior Investigator with the TIMI study group. He attends in the Levine Cardiovascular Intensive Care Unit and general Cardiology service at Brigham and Women's Hospital.As an investigator, Dr. Wiviott has played important roles in the planning, implementation, leadership, and interpretation of multicenter, national, and international clinical trials in acute coronary syndromes including the TRITON-TIMI 38 trial, PRINCIPLE-TIMI 44 and of the TIMI 38 Coronary Stent Registry. He has also served in leadership of trials of secondary prevention of cardiovascular disease as global PI of DECLARE – TIMI 58, CAMELLIA – TIMI 61, and DAPA ACT HF – TIMI 68 assessing CV safety and efficacy of metabolic therapies.  He is the Chairman of the TIMI Clinical Events Committee and recognized as an expert in event definitions and adjudications.  Dr. Wiviott is an author of over 200 peer-reviewed publications in major medical and cardiovascular journals including 15 original articles in the New England Journal of Medicine. He was named in 2014 and 2017 by Thomson Reuters and Clarivate Analytics as one of “The World’s Most Influential Scientific Minds” and in 2016-2020 as a “Highly Cited Researcher,” recognitions inclusive of the top 1% of researchers in Clinical Medicine by citation.  Building on his trials experience, Dr. Wiviott serves as Vice President for Clinical Trials Research and Administration for Mass General Brigham and leads the Mass General Brigham Clinical Trials Office.  The CTO provides contracting, budgeting, and clinical trial management services for Mass General Brigham hospital investigators and industry sponsors and is tasked with supporting and growing clinical trials research at Mass General Brigham. Dr. Wiviott is rated as an Experienced provider by MediFind in the treatment of Metabolic Syndrome. His top areas of expertise are Heart Attack, Acute Coronary Syndrome, Atrial Fibrillation, Percutaneous Coronary Intervention (PCI), and Angioplasty.

Dr. Peter H. Stone is director of the Vascular Profiling Research Group and the Cardiovascular Division Faculty Mentorship Program at Brigham and Women’s Hospital. A cardiovascular medicine specialist, he is also a professor of medicine at Harvard Medical School.Dr. Stone received his medical degree from Weill Cornell Medical College. He completed an internal medicine residency at University of California, San Francisco Medical Center, a cardiology fellowship at Pacific Medical Center (now California Pacific Medical Center) and cardiology research fellowship at Peter Bent Brigham Hospital. Dr. Stone is board certified in internal medicine and cardiovascular disease.His research focuses on coronary artery disease (CAD), specifically the vascular biology of atherosclerosis, innovative strategies to risk-stratify individual coronary plaques and novel pharmacologic and device CAD therapies. He leads multicenter clinical trials investigating risk assessment of coronary plaques, and new anti-ischemia therapies. He has written over 190 peer-reviewed publications and received research funding from the National Institutes of Health. Dr. Stone is rated as an Experienced provider by MediFind in the treatment of Metabolic Syndrome. His top areas of expertise are Atrial Fibrillation, Sitosterolemia, Hypertension, Pacemaker Implantation, and Cardiac Ablation.

Dr. Raymond Y. Kwong is the director of Cardiac Magnetic Resonance Imaging (MRI) at Brigham and Women’s Hospital (BWH). A cardiovascular medicine specialist, he is also a professor of medicine at Harvard Medical School (HMS).Dr. Kwong received his medical degree from University of Toronto Faculty of Medicine. He completed a residency in internal medicine at Vancouver General Hospital and a fellowship in cardiovascular disease at The George Washington University Hospital. He then completed a cardiac MRI fellowship program at the National Heart, Lung and Blood Institutes of Health. Dr. Kwong is board certified in internal medicine and cardiovascular disease.He has authored over 290 peer-reviewed publications. His clinical interests and research focus on cardiac imaging, specifically the use of cardiac MRI to assess ventricular remodeling after acute myocardial infarction. He has received multiple grants from the National Institutes of Health, American Heart Association, Canadian Institute of Health Research, and the Society for Cardiovascular Magnetic Resonance for his research. Dr. Kwong is rated as an Experienced provider by MediFind in the treatment of Metabolic Syndrome. His top areas of expertise are Cardiomyopathy, Cardiac Amyloidosis, Hypertrophic Cardiomyopathy (HCM), Cardiac Ablation, and Heart Transplant.

Dr. Gregory Piazza is a cardiovascular medicine specialist at Brigham and Women’s Hospital (BWH). He is also an associate professor of medicine at Harvard Medical School (HMS).Dr. Piazza received his medical degree from University of Massachusetts Medical School. He completed a residency in internal medicine and fellowships in cardiology and advanced cardiovascular imaging at Beth Israel Deaconess Medical Center. He also served as chief medical resident at Beth Israel Deaconess Medical Center. He then completed a fellowship in vascular medicine at BWH. Dr. Piazza is board certified in internal medicine, cardiovascular disease, vascular medicine and echocardiography.Dr. Piazza’s practice focuses on the evaluation, management and prevention of venous thromboembolism (VTE), thrombosis-related infertility, and stroke prevention in atrial fibrillation. The author of over 140 peer-reviewed publications, his research investigates innovative treatment of VTE, thrombosis-related infertility, and prevention of stroke. Dr. Piazza has received research support from the National Institutes of Health."". Dr. Piazza is rated as an Experienced provider by MediFind in the treatment of Metabolic Syndrome. His top areas of expertise are Pulmonary Embolism, Deep Vein Thrombosis, Venous Thromboembolism (VTE), Embolectomy, and Thrombectomy.

Arvind Pandey is a Cardiologist in Jamaica Plain, Massachusetts. Dr. Pandey is rated as an Experienced provider by MediFind in the treatment of Metabolic Syndrome. His top areas of expertise are Hypertension, Venous Thromboembolism (VTE), Shwartzman Phenomenon, and Fainting.

Dr. Pinak Bipin Shah is director of the Cardiac Catheterization Laboratory at Brigham and Women’s Hospital (BWH). A cardiovascular medicine specialist, he is also an associate professor of medicine at Harvard Medical School.He received his medical degree from Perelman School of Medicine at the University of Pennsylvania. He completed an internal medicine residency at BWH and served as chief medical resident. He then completed fellowships in cardiovascular disease, interventional cardiology and cardiovascular clinical biometrics at BWH. He is board certified in cardiovascular disease and interventional cardiology.Dr. Shah’s clinical interests include catheterization based techniques for the treatment of complex valvular and structural heart disease as well as complex coronary intervention. Dr. Shah’s practice focuses on trans-catheter aortic valve replacement (TAVR), mitral valve interventions, PFO/ASD closure, alcohol septal ablation for hypertrophic cardiomyopathy, and high-risk percutaneous coronary intervention (PCI) cases. Dr. Shah has received research funding from the Massachusetts Department of Public Health and National Heart, Lung and Blood Institute. He has also been listed one of America’s Top Doctors by Castle Connolly. Dr. Shah is rated as an Experienced provider by MediFind in the treatment of Metabolic Syndrome. His top areas of expertise are Aortic Valve Stenosis, Mitral Valve Regurgitation, Mitral Stenosis, Aortic Valve Replacement, and Transcatheter Aortic Valve Replacement (TAVR).

Dr. Piotr S. Sobieszczyk is a member of the interventional cardiology team at Brigham and Women’s Hospital (BWH). A cardiovascular specialist, he is also an instructor in medicine at Harvard Medical School.He received his medical degree from Columbia University College of Physicians and Surgeons. He completed an internal medicine residency at Massachusetts General Hospital, as well a peripheral arterial and venous interventions fellowship at BWH. He then completed fellowships in interventional cardiology and interventional vascular medicine at BWH. Dr. Sobieszczyk is board certified in internal medicine, cardiovascular disease and interventional cardiology.Dr. Sobieszczyk’s clinical interests include carotid artery disease, structural heart disease, ventricular assist devices and high-risk coronary intervention. His research focuses on the medical and endovascular management of complex cardiovascular disease, including the management of peripheral artery disease. He has received research funding from the National Institutes of Health. Dr. Sobieszczyk is rated as an Experienced provider by MediFind in the treatment of Metabolic Syndrome. His top areas of expertise are Peripheral Artery Disease, Aortic Valve Stenosis, Arterial Insufficiency, Aortic Valve Replacement, and Transcatheter Aortic Valve Replacement (TAVR).

Dr. Anju Nohria is the Director of the Cardio-Oncology Program at Dana-Farber Brigham Cancer Center and a cardiovascular medicine specialist at Brigham and Women’s Hospital (BWH). In addition, she is an Associate Professor of Medicine at Harvard Medical School (HMS).Dr. Nohria received her medical degree from HMS. She completed an internal medicine residency and was a chief resident at Yale-New Haven Hospital. She then completed both a cardiovascular medicine fellowship and a heart failure and transplantation fellowship at BWH. She is board certified in cardiovascular disease and heart failure and transplantation.Dr. Nohria’s clinical interests include cardio-oncology and heart failure and transplantation. The author of over 100 peer-reviewed publications, she currently researches how to evaluate, prevent and treat cardiovascular complications that can arise as a consequence of cancer therapy. Dr. Nohria is rated as an Experienced provider by MediFind in the treatment of Metabolic Syndrome. Her top areas of expertise are Myocarditis, Cardiomyopathy Due to Anthracyclines, Cardiomyopathy, Heart Transplant, and Cardiac Ablation.

Dr. Jane A. Leopold is the director of the Women's Interventional Cardiology Health Initiative at Brigham and Women’s Hospital (BWH). An interventional cardiovascular medicine specialist, she is also an associate professor of medicine at Harvard Medical School (HMS).She received her medical degree at Boston University School of Medicine. She completed a residency in internal medicine at Beth Israel Deaconess Medical Center and two fellowships at Boston Medical Center—cardiovascular disease and interventional cardiology. Dr. Leopold is board certified in cardiovascular disease and interventional cardiology.Dr. Leopold developed the Women’s Interventional Cardiology Health Initiative at BWH, which uses advanced invasive diagnostic imaging and functional assessment devices to diagnose chest pain syndromes in women. The author of over 100 peer-reviewed publications, Dr. Leopold’s research interests include preclinical and clinical studies in pulmonary arterial hypertension and she is the principal investigator of a National Institutes of Health funded center at BWH to perform deep phenotyping in patients with Groups 1-5 pulmonary hypertension. She also studies mechanisms by which aldosterone influences vascular structure and function and cardiovascular disease in women. Her research has received support from the National Institutes of Health and the American Heart Association. Dr. Leopold is rated as an Experienced provider by MediFind in the treatment of Metabolic Syndrome. Her top areas of expertise are Pulmonary Hypertension, Hypertension, Heart Attack, Angioplasty, and Percutaneous Coronary Intervention (PCI).